share_log

中國人壽：保險公司償付能力季度報告摘要（2024年第1季度）

CHINA LIFE: Summary of Solvency Quarterly Report of Insurance Company (First Quarter of 2024)

Hong Kong Stock Exchange ·  Apr 26 06:44
Summary by Moomoo AI
中國人壽保險股份有限公司（中國人壽）於2024年第1季度發布了保險公司償付能力報告摘要。報告顯示，公司核心償付能力充足率為154.97%，綜合償付能力充足率為209.17%，均遠高於監管要求，顯示公司償付能力充足。報告期內，認可資產增加至5,981.97億元人民幣，認可負債增至4,986.56億元人民幣。實際資本增加至995.41億元人民幣。最低資本增加至475.88億元人民幣。公司經營活動淨現金流為103.64億元人民幣，流動性風險監管指標均達到監管標準。此外，公司面臨的主要風險包括聲譽風險和流動性風險，但公司已採取相應措施進行管理。普華永道中天會計師事務所對公司2023年度財務報表進行了審計，認為公司財務報表公允反映了公司的財務狀況。截至報告日，公司董事會由執行董事白濤、利明光，非執行董事王軍輝、卓美娟，以及獨立非執行董事林志權、翟海濤、黃益平、陳潔組成。
中國人壽保險股份有限公司（中國人壽）於2024年第1季度發布了保險公司償付能力報告摘要。報告顯示，公司核心償付能力充足率為154.97%，綜合償付能力充足率為209.17%，均遠高於監管要求，顯示公司償付能力充足。報告期內，認可資產增加至5,981.97億元人民幣，認可負債增至4,986.56億元人民幣。實際資本增加至995.41億元人民幣。最低資本增加至475.88億元人民幣。公司經營活動淨現金流為103.64億元人民幣，流動性風險監管指標均達到監管標準。此外，公司面臨的主要風險包括聲譽風險和流動性風險，但公司已採取相應措施進行管理。普華永道中天會計師事務所對公司2023年度財務報表進行了審計，認為公司財務報表公允反映了公司的財務狀況。截至報告日，公司董事會由執行董事白濤、利明光，非執行董事王軍輝、卓美娟，以及獨立非執行董事林志權、翟海濤、黃益平、陳潔組成。
China Life Insurance Co., Ltd. (China Life) issued a summary of the insurance company's ability to pay report for the first quarter of 2024. The report shows that the company's core solvency ratio is 154.97% and the comprehensive solvency ratio is 209.17%, which is well above regulatory requirements, indicating that the company is solvent. During the reporting period, authorized assets increased to RMB5,981.97 billion and authorized liabilities increased to RMB4,986.56 billion. Actual capital increased to RMB 995.41 billion. The minimum capital increased to RMB 475.88 billion. The company's net cash flow from operating activities was RMB103.64 billion, and liquidity risk regulatory indicators met regulatory standards. In addition, the main risks faced by the company include reputational risk and liquidity risk, but the company has taken...Show More
China Life Insurance Co., Ltd. (China Life) issued a summary of the insurance company's ability to pay report for the first quarter of 2024. The report shows that the company's core solvency ratio is 154.97% and the comprehensive solvency ratio is 209.17%, which is well above regulatory requirements, indicating that the company is solvent. During the reporting period, authorized assets increased to RMB5,981.97 billion and authorized liabilities increased to RMB4,986.56 billion. Actual capital increased to RMB 995.41 billion. The minimum capital increased to RMB 475.88 billion. The company's net cash flow from operating activities was RMB103.64 billion, and liquidity risk regulatory indicators met regulatory standards. In addition, the main risks faced by the company include reputational risk and liquidity risk, but the company has taken appropriate management measures. Pwai Wing Road Central Accounting Firm audited the company's financial statements for 2023, considering that the company's financial statements reflect the financial situation of the company fairly. As of the reporting date, the Company's Board of Directors consists of Executive Directors Baitao, Li Ming Kwong, Non-Executive Directors Wang Junhui, Cheung Mei Juan, and Independent Non-Executive Directors Lin Zhiquan, Zhai Haitao, Huang Yiping, and Chen Jie.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more